Penester - a treatment for benign prostatic hyperplasia.
The composition and the form of Penestera
Penester produced in the form of circular tablets, film-coated light yellow color. 1 tablet contains active ingredient - 5 mg finasteride. Auxiliary components: magnesium stearate, povidone 30, lactose monohydrate, sodium carboxymethylstarch, corn starch, sodium docusate.
The blister packs of 10 or 15 pieces.
Active component of the drug - a synthetic 4-azasteroid compound, which is a specific and competitive inhibitor of steroid 5-alpha reductase (intracellular enzyme that converts testosterone to the active androgen DHT-5).
Application Penestera Review significantly reduces the concentration of DHT in the prostate tissue and in plasma. As a result of this decrease in prostate size and symptoms disappear, causing its hyperplasia.
According to the instructions Penester indicated for benign prostatic hyperplasia. He was appointed to achieve the following effects:
- increase the maximum speed of the flow of urine;
- reducing the size of the prostate gland;
- disappearance of symptoms caused by hyperplasia;
- the disappearance of the risk of acute urinary retention.
Dosing and dosing regimen Penestera
According to the instructions Penester intended for ingestion. As a general rule, appoint one tablet once a day.
The duration of therapy Penesterom according to the instructions shall be not less than six months.
In the opinion of Penester 50% of patients causes the disappearance of symptoms during treatment duration of at least six months.
According to the instructions Penester contraindicated apply:
- in childhood;
- obstruction of the urinary tract;
- prostate cancer;
- in case of hypersensitivity to the drug.
If abnormal liver function Penester used with caution.
In the opinion of Penester can cause such side effects from the reproductive system: pain in the breasts, decreased libido, gynecomastia, decrease in ejaculate.
There were also reviews of Penestere the occurrence of allergic reactions.
Currently no reviews Penestere regarding overdose has been reported.
Application Penestera during pregnancy and lactation
Pregnant women and women of childbearing age are urged not to contact the crushed tablets of the drug, since it has the ability to convert testosterone into dihydrotestosterone, which can cause developmental disorders of sex organs in a male fetus.
Through contact film coated with the active substance while preserving the integrity Penestera tablets removed.
Shelf life and storage conditions Penestera
The drug is stored in a place inaccessible to children for no longer than three years.